Neoleukin Therapeutics Stock Forecast - Period Momentum Indicator
| NLTXDelisted Stock | USD 0.69 0.01 1.43% |
Neoleukin Stock Forecast is based on your current time horizon.
Neoleukin |
| Previous Period Momentum Indicator | Period Momentum Indicator | Trend |
| (0.01) | (0.01) |
| Check Neoleukin Therapeutics Volatility | Backtest Neoleukin Therapeutics | Information Ratio |
Neoleukin Therapeutics Trading Date Momentum
| On November 13 2024 Neoleukin Therapeutics was traded for 0.69 at the closing time. The top price for the day was 0.71 and the lowest listed price was 0.67 . There was no trading activity during the period 0.0. Lack of trading volume on November 13, 2024 did not cause price change. The trading delta at closing time against the current closing price is 1.45% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare Neoleukin Therapeutics to competition
Neoleukin Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neoleukin Therapeutics stock to make a market-neutral strategy. Peer analysis of Neoleukin Therapeutics could also be used in its relative valuation, which is a method of valuing Neoleukin Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Neoleukin Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Neoleukin Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neoleukin Therapeutics shares will generate the highest return on investment. By undertsting and applying Neoleukin Therapeutics stock market strength indicators, traders can identify Neoleukin Therapeutics entry and exit signals to maximize returns.
Neoleukin Therapeutics Risk Indicators
The analysis of Neoleukin Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neoleukin Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neoleukin stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.25 | |||
| Standard Deviation | 3.7 | |||
| Variance | 13.69 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Neoleukin Stock
If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |